000 01791 a2200517 4500
005 20250514210057.0
264 0 _c20041130
008 200411s 0 0 eng d
022 _a0008-5472
024 7 _a10.1158/0008-5472.CAN-04-2361
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTourneur, Léa
245 0 0 _aAbsence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome.
_h[electronic resource]
260 _bCancer research
_cNov 2004
300 _a8101-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdaptor Proteins, Signal Transducing
_xanalysis
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aBlotting, Western
650 0 4 _aCaspases
_xphysiology
650 0 4 _aCell Line, Tumor
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aFas-Associated Death Domain Protein
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aLeukemia, Myeloid, Acute
_xdrug therapy
650 0 4 _aMicroscopy, Confocal
650 0 4 _aMicroscopy, Fluorescence
650 0 4 _aMiddle Aged
650 0 4 _aPrognosis
650 0 4 _afas Receptor
_xanalysis
700 1 _aDelluc, Stéphanie
700 1 _aLévy, Vincent
700 1 _aValensi, Françoise
700 1 _aRadford-Weiss, Isabelle
700 1 _aLegrand, Ollivier
700 1 _aVargaftig, Jacques
700 1 _aBoix, Charlotte
700 1 _aMacintyre, Elizabeth A
700 1 _aVaret, Bruno
700 1 _aChiocchia, Gilles
700 1 _aBuzyn, Agnès
773 0 _tCancer research
_gvol. 64
_gno. 21
_gp. 8101-8
856 4 0 _uhttps://doi.org/10.1158/0008-5472.CAN-04-2361
_zAvailable from publisher's website
999 _c15208365
_d15208365